Compounds > citric acid, anhydrous

citric acid, anhydrous and mci 9038

citric acid, anhydrous has been researched along with mci 9038 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Apkarian, RP; Dublin, SN; Levy, JH; Sun, H; Tanaka, KA1
Kalb, ML; Kozek-Langenecker, SA; Potura, L; Scharbert, G1
Barbar, T; Bhasin, A; Gerardine, S; Lamba, P; Leuprecht, L; Liu, F; Muthukumar, T; Neupane, SP; Salinas, T; Shankaranarayanan, D; Shimonov, D; Varma, E1
Arnold, F; Biever, PM; Kalbhenn, J; Neumann-Haefelin, E; Rieg, S; Tanriver, Y; Walz, G; Westermann, L1

Other Studies

4 other study(ies) available for citric acid, anhydrous and mci 9038

ArticleYear
Scanning electron microscopical observations of two novel hemostatic polymers.
    Journal of thrombosis and haemostasis : JTH, 2005, Volume: 3, Issue:7

    Topics: Aluminum; Anticoagulants; Arginine; Calcium Chloride; Citric Acid; Hemostasis; Hemostatics; Humans; Microscopy, Electron, Scanning; Pipecolic Acids; Polymers; Sulfonamides; Time Factors

2005
The effect of ex vivo anticoagulants on whole blood platelet aggregation.
    Platelets, 2009, Volume: 20, Issue:1

    Topics: Adenosine Diphosphate; Anticoagulants; Arachidonic Acid; Arginine; Azetidines; Benzylamines; Blood Platelets; Citric Acid; Collagen; Female; Heparin; Hirudins; Humans; Male; Peptide Fragments; Pipecolic Acids; Platelet Aggregation; Platelet Function Tests; Recombinant Proteins; Ristocetin; Sulfonamides; Time Factors

2009
Anticoagulation Strategies and Filter Life in COVID-19 Patients Receiving Continuous Renal Replacement Therapy: A Single-Center Experience.
    Clinical journal of the American Society of Nephrology : CJASN, 2020, 12-31, Volume: 16, Issue:1

    Topics: Acute Kidney Injury; Aged; Anticoagulants; Arginine; Citric Acid; Continuous Renal Replacement Therapy; COVID-19; Disposable Equipment; Equipment Failure; Female; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Pipecolic Acids; SARS-CoV-2; Sulfonamides; Time Factors

2020
Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study.
    BMC nephrology, 2020, 11-16, Volume: 21, Issue:1

    Topics: Acute Kidney Injury; Adult; Aged; Anticoagulants; Arginine; Betacoronavirus; Blood Coagulation; Citric Acid; Comorbidity; Coronavirus Infections; COVID-19; Critical Care; Critical Illness; Equipment Failure; Female; Germany; Heparin; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Pandemics; Pipecolic Acids; Pneumonia, Viral; Renal Replacement Therapy; Retrospective Studies; SARS-CoV-2; Sulfonamides; Tertiary Care Centers

2020